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  9 
Abstract 10 
 11 
In humans, epilepsy can induce or accelerate cognitive impairment (CI). There is emerging 12 
evidence of cognitive impairment in dogs with idiopathic epilepsy (IE) from recent 13 
epidemiological studies. The aim of our study was to assess CI in dogs with IE using two tests 14 
of cognitive dysfunction designed for use in a clinical setting. Dogs with IE (n=17) were 15 
compared against controls (n=18) in their performance in two tasks; a spatial working memory 16 
task and a problem-solving task. In addition, owners completed the Canine Cognitive 17 
Dysfunction rating (CCDR) scale for their dog. The groups did not differ statistically with 18 
respect to age and breed. Dogs with IE performed significantly worse than controls on the 19 
spatial working memory task (P=0.016) but not on the problem solving task (P=0.683). CCDR 20 
scores were significantly higher in the IE group (P=0.016), however no dogs reach the 21 
recommended threshold score for CCD diagnosis. Our preliminary data suggests that dogs with 22 
IE exhibit impairments in a spatial working memory task. Further research is required to 23 
explore the effect of IE on other cognitive abilities in dogs with a larger sample, characterising 24 
the age of onset, nature and progression of any impairments, and the impact of anti-epileptic 25 
drugs. 26 
  27 
1.0 Introduction 28 
 29 
Idiopathic epilepsy (IE) is the most common chronic neurological disorder in humans 30 
and dogs, with an estimated prevalence of 0.62% in the general UK canine population 31 
(Kearsley-Fleet et al., 2013). Many similarities exist between human and canine epilepsy, with 32 
dogs proposed as a model of human epilepsy (Potschka et al., 2013). Epilepsy in humans is 33 
recognised to be associated with an increased risk of psychiatric disorders (Austin and Caplan, 34 
2007; Tellez-Zenteno, 2007) and cognitive impairment (Elger, 2004; Breuer et al., 2016). In 35 
canine IE, behavioural changes such as ADHD-like behaviour (Jokinen et al., 2015; Packer et 36 
al., 2016), increased fear, anxiety, abnormal perception and demented behaviour have been 37 
documented (Shihab, Bowen and Volk, 2011) and there is emerging evidence of co-morbid 38 
cognitive impairments (Packer, 2017; Packer, In Press). 39 
 40 
Epilepsy is known to induce or exacerbate underlying cognitive impairments in people 41 
(Motamedi, 2003), with recent studies indicating that approximately half of newly diagnosed 42 
children or adults with epilepsy have demonstrable cognitive or behavioural difficulties 43 
(Taylor, 2010; Witt, 2012; Witt, 2014). One key area of cognition, working memory, has been 44 
found to be impaired in human epilepsy studies. Working memory deficits have been observed 45 
in several epilepsy syndromes including Juvenile Myoclonic Epilepsy, Benign Childhood 46 
Epilepsy with Centro-Temporal Spikes and Temporal Lobe Epilepsy (TLE) (Hommet et al., 47 
2006). Rodent models of TLE display deficits in spatial working memory with inferior 48 
performance in the Morris Water Maze task (Anisman and McIntyre, 2002; Szyndler et al., 49 
2006). Tasks have been devised in canine behaviour science to test spatial working memory, 50 
which is impaired in dogs with age-related cognitive dysfunction (Gonzalez-Martinez et al., 51 
2013). 52 
 53 
The aim of our study was to investigate whether dogs with IE exhibit signs of cognitive 54 
impairment in two tasks designed to assess spatial working memory and problem solving 55 
ability. 56 
 57 
2.0 Materials and Methods 58 
 59 
2.1 Animals 60 
The effects of canine IE on spatial working memory and problem-solving ability was 61 
investigated in a cohort of dogs with IE and controls recruited from the Royal Veterinary 62 
College (RVC) Small Animal Referral Hospital, general veterinary practices and social media. 63 
Inclusion criteria for the IE group followed International Veterinary Epilepsy Task Force tier I 64 
guidelines (De Risio, 2015).  These are; (i) A history of two or more seizures, occurring at least 65 
24 hours apart (ii) Age of seizure onset between 6 months and 6 years of age (iii) Unremarkable 66 
inter-ictal physical and neurological exam [except for anti-epileptic drug (AED) induced 67 
abnormalities] (iv) No clinically significant abnormalities on minimum-database blood and 68 
urine tests. 69 
 70 
The inclusion criteria for the control group were (i) No primary organ system failure, 71 
severe vision or mobility deficits; (ii) No history of seizure(s); (iii) No diagnosed neurological 72 
disorder. Control dogs were matched by breed and age to the IE cohort as closely as possible 73 
(see supplementary table 1 for full demographic details of both groups); the two groups did not 74 
differ statistically with respect to age and breed. The study was given ethical approval by the 75 
RVC welfare and ethics committee (2016-U175). 76 
 77 
2.2 Epilepsy specific data 78 
 Once each dog with IE had met the inclusion criteria, all owners of dogs with IE were 79 
asked to provide information on their dogs’ current AED therapy such as the date it commenced 80 
and drugs used, how many seizures per month on average their dog experienced preceding the 81 
most recent treatment alteration (defined as addition of an AED) and the same information 82 
since after this date. From this information, we determined whether the dogs had shown a 83 
complete response to medication (seizure freedom), a partial response (>50% reduction in 84 
seizure frequency) or no response (<50% reduction in seizure frequency). Other information 85 
gathered included duration of IE, whether or not there was a history of cluster seizures or status 86 
epilepticus, and estimated total number of seizures. 87 
 88 
2.3 Testing procedure 89 
Several methods have been investigated for assessing spatial working memory and 90 
problem solving ability in dogs (Gonzalez-Martinez et al., 2013). Two cognition tasks validated 91 
by Gonzalez-Martinez et al (2013) in a study of cognitive dysfunction were chosen for their 92 
speed and ease of performance in a clinical setting, with no requirement for prior training or 93 
special equipment. Task one was designed to assess spatial working memory, whilst task two 94 
aimed to assess problem solving ability.  95 
 96 
2.3.1 Task 1: Spatial working memory 97 
The food searching task aims to test the dog’s spatial working memory, assessing 98 
ability to search and find a food reward (ham), the location of which had previously been 99 
indicated to them through vocalisation and pointing to the reward. The tasks begins with the 100 
handler holding the dog in the centre of the room on a leash. The tester stood in front of the 101 
dog, showed it the reward (a small piece of ham) and moved backwards, shaking the hand 102 
containing reward whilst maintaining visual contact and repeatedly saying the dogs name in a 103 
positive tone. The food was placed in one corner of the room which alternated for each of the 104 
three repeats (Figure 1). Once there, the tester pointed at the food for 2 seconds, ensuring the 105 
dog’s attention through calling their name. The handler then led the dog out of the room for 106 
15 seconds. After 15 seconds the dog was reintroduced into a fixed position at the centre of 107 
the room, the leash removed and the dog allowed to explore the room for 1 minute. During 108 
the minute, tester and dog handler stood to the side, ensuring no communication with the dog 109 
(no verbal/physical cues or eye contact). Each repeat ended when the food was found or after 110 
1 minute if the reward was not found.  111 
 112 
2.3.2 Task 2: Problem solving 113 
The problem solving task aims to test the dog’s problem solving ability to access a 114 
hidden food reward. To access the food, the dog must manipulate an object (a transparent 115 
plastic box) that acts as a barrier to the reward. To begin the task, the tester showed the dog 116 
the reward (three pieces of ham), allowing the dog to lick and sniff the hand containing the 117 
reward to ensure they were aware of it. The reward was placed on the floor and covered with 118 
a transparent plastic box. The dog was given two minutes to attempt to gain access to and 119 
consume the reward, during which, the handler could encourage the dog to find the food and 120 
point towards the box. This task was repeated three times.  121 
 122 
2.3.3 Modifications to tasks 123 
Slight modifications were made to the tasks from the original published protocol;  124 
(i) Each task was repeated three times to improve reliability, with a median score given for 125 
overall performance across all trials.  126 
(ii) For Task 1, the location of the reward was altered for each repeat to reduce learning effects 127 
of the reward location.  128 
Alterations were also made to the scoring system published by Gonzalez-Martinez et al. (2013): 129 
(i) The scoring system was altered for Task 1; dogs were not given two further attempts for 130 
each repeat (thus scoring out of 12 for each repeat) if they failed to find the food reward 131 
within one minute and instead had one attempt at each repeat, scored out of 4.  132 
 133 
The Task 1 scoring system was as follows:  134 
1= Goes directly towards the food,  135 
2= Finds the food within 1 minute,  136 
3= Searches for the food without finding it within 1 minute,  137 
4= Makes no attempt to search for the food.  138 
The Task 2 scoring system was as follows: 139 
 1= Obtains all food within maximum of 2 minutes, 140 
 2= Tries to get food but does not obtain all of it within maximum of 2 minutes, 141 
 3= Sniffs the box but does not try to get the food, 142 
 4= Makes no attempt to get the food. 143 
 144 
The tasks were performed in a controlled environment with no external distractions 145 
(blinds closed, in a quiet area) and without the owner present. The investigator was the same 146 
for each dog (JW).  147 
 148 
2.4 Questionnaire 149 
All owners completed a questionnaire; the canine cognitive dysfunction rating scale 150 
(CCDR). This is a psychometrically validated tool that quantifies the frequency and 151 
progression of thirteen behaviours which, when abnormal, fit with veterinary diagnoses of 152 
canine dementia almost 80% of the time (Salvin et al., 2011). The CCDR focuses on problems 153 
related to memory, orientation, apathy, impaired olfaction and locomotion. Questions are 154 
included in Supplementary table 2, with dogs receiving an overall score out of 80. The 155 
diagnostic threshold for CCD is set at ≥50. 156 
 157 
2.5 Statistical Analysis 158 
 159 
 Live scoring data for task 1 and 2 were collated in Microsoft Excel and transferred to 160 
IBM SPSS v23 for statistical analysis. Each dog received an overall median score for their 161 
performance in task 1 and task 2. Dogs in the IE group were separated into those exhibiting a 162 
partial AED response (>50% reduction in seizures) and no response. Partial AED response 163 
was selected over complete AED response (seizure freedom) as only 2/15 dogs in the IE 164 
group were seizure free. Six dogs (E16 and E17 and C15, C16, C17 and C18) were too 165 
anxious to perform the tasks (e.g. scratching at the door, vocalising, uninterested in the food 166 
reward) so were excluded from the analyses. Dog E15 could perform task 2 but not task 1 due 167 
to severe ataxia and lethargy (AED side effects), thus was excluded from task 1 analysis. 168 
Overall median score for both tasks and CCDR scores were compared between groups and 169 
between partial responders/ non responders with a Mann Whitney U test. Age was compared 170 
between groups with an independent samples t-test. A Friedman test was used to assess the 171 
presence of a learning effect between repeats for task 1 and 2. Where medians are reported, 172 
they are in the format: (Median [25th percentile- 75th percentile]). 173 
 174 
3.0 Results 175 
 176 
A total of 35 dogs were recruited into the study; 17 with IE and 18 controls (see 177 
supplementary table 2) with 14 IE and 14 controls featuring in task 1 analysis, and 15 IE and 178 
14 controls featuring in task 2 analysis. Within the IE group, nine dogs were considered partial 179 
AED responders and five non-responders, with one dog drug naive. The mean age of the control 180 
group was 63 months (standard deviation: 28) and the IE group 60 months (standard deviation: 181 
25).  An independent samples t-test revealed no significant age difference between groups.  182 
 183 
A Mann-Whitney U test found a significant difference (MU=46.0, P=0.016,) between 184 
groups for performance (median score of the 3 repeats) in Task 1 (IE: 2 [1-2] versus controls: 185 
1 [1-1], figure 2), but not for Task 2 (MU=95.0, P=0.683) (IE: 1 [1-2] versus controls: 1 [1-2] 186 
(Table 1). CCDR scores differed significantly between groups (MU= 50.5, P=0.016) (median 187 
score for IE group: 35 [34-38] versus controls: 34 [34-34], figure 3) and no dogs achieved a 188 
score of 50 or higher, the threshold for CCD diagnosis using this tool (Salvin et al 2011).  189 
 190 
A Friedman test revealed no significant difference between repeats for the IE group in 191 
task 1 (P=0.08, median for IE group: repeat 1; 2 [1.75-3.25], repeat 2; 2 [1-2]. Repeat 3; 2 [1-192 
2]) or 2 (P=0.81, median for IE group: repeat 1; 1 [1-2]. Repeat 2; 1 [1-2]. Repeat 3; 1 [1-2]).  193 
 194 
Within the group with IE, there was no significant difference in task 1 (P=0.524), 2 195 
(P=0.606) or CCDR score (P=0.699) between dogs that were partial drug responders (n=9) and 196 
those that were not (n=5). 197 
 198 
Post-hoc power analyses were conducted for both tasks. For task 1 (comparing 2 groups 199 
in a 2-sided test) a power of 0.76 was detected at a type I error rate of 5%; for task 2 a power 200 
of 0.08 was detected at a type I error rate of 5%. 201 
4.0 Discussion 202 
 203 
Our Task 1 findings, in combination with data from studies of humans with epilepsy 204 
and rodent models of epilepsy, suggest that dogs with IE may also display spatial working 205 
memory deficits. The majority of dogs in the IE group (13/14) made attempts to search for the 206 
food reward when re-introduced to the testing area, but did not go directly towards it when let 207 
off leash.  This may indicate that the majority of dogs remembered the presence of a food 208 
reward in the testing area, but not its precise location. This may suggest that impairment is 209 
greater in spatial orientation than working memory; indeed, in a study in children with epilepsy 210 
of genetic origin, children performed worse in a spatial orientation task but had no working 211 
memory deficits, though this must be interpreted with caution due to the small sample size and 212 
demographic studied (n=10 8-9 year old boys with genetic generalised epilepsy) (Cimadevilla 213 
et al., 2014). Although the hippocampal system is well-known to be involved in memory and 214 
spatial learning functions, egocentric (body-centred) spatial representations are modulated by 215 
extratemporal regions such as the parietal cortices and subcortical regions (Burgess, 2001). 216 
Human studies have identified that patients with temporal lobe epilepsy demonstrate strong 217 
egocentric memory impairments in a virtual maze task (Weniger, 2012). In the same study, 218 
smaller volumes of the left-sided postcentral gyrus were related to worse task performance, 219 
which may indicate parietal cortex damage. As brain imaging was not available for the dogs in 220 
this study, future work should explore the relationship between cognitive function and 221 
volumetric analysis of relevant brain regions. 222 
 223 
Four (29%) of the epilepsy group scored 1 (the best possible score) on task 1, suggesting 224 
that not all dogs with IE display cognitive impairment on this task. Canine epilepsy phenotypes 225 
are heterogeneous, and cognitive impairment may vary based on a number of clinical factors 226 
(e.g. seizure frequency, severity, type, and age of onset) (Breuer et al., 2016). This may also 227 
explain the increased variability in performance observed in the IE group compared with the 228 
control group. Due to the relatively small sample size of this preliminary study, within group 229 
effects cannot be fully analysed in this study population, but future larger scale studies should 230 
investigate the impact of clinical and treatment based factors.  231 
 232 
A limitation of this study is the lack of drug naïve dogs in the IE group; further studies 233 
require a more balanced sample of drug naïve to AED treated dogs to examine individual AED 234 
effects. In human medicine, the cognitive effects of AEDs are mixed (Breuer et al., 2016), but 235 
dose-dependent negative effects of AEDs on cognitive functioning have been documented. 236 
with maximal impairments seen in patients receiving polytherapy (Trimble, 1987). 237 
Polyphagia is a common AED side effect in dogs with IE, associated with both first and 238 
second-line AEDs including phenobarbital, imepitoin and potassium bromide 239 
(Charalambous, 2016). It is possible that polyphagia may have affected the results of these 240 
tasks by increasing food motivation in some AED-treated dogs, and potentially increasing 241 
their persistence in attempting to access the food rewards. As such, polyphagia is more likely 242 
to enhance rather than inhibit performance in these tasks, which would not explain the poorer 243 
results seen in dogs with IE compared to controls presented here. As previously noted, one 244 
dog was unable to perform in the tasks due to the AED side effects ataxia and lethargy. This 245 
was especially evident in Task 1 which requires a degree of agility to move in and out of the 246 
room. As AED side effects are often most pronounced in the first two weeks of therapy, 247 
assessing cognition in dogs with IE once they are on a stable dose is likely to yield more 248 
reliable results, and for future studies, side effect screening before testing is advocated. In 249 
addition, developing cognitive tasks that require limited physical abilities would allow their 250 
application to a wider group of animals. Four of the control group and two of the IE group 251 
were unable to perform the tasks due to high levels of anxiety, thus reducing the utility of these 252 
tasks to assess cognition in anxious dogs. Dogs with IE have been shown to display increased 253 
anxiety behaviours following the onset of epilepsy (Shihab, Bowen and Volk, 2011) and so 254 
this may negatively affect how useful these tasks are to measure cognitive abilities in dogs with 255 
IE.  It should be noted that both tasks were performed without the owner present to improve 256 
consistency of the handler. Separation anxiety is a common finding in the general population 257 
of dogs without IE, and in a previous longitudinal study of Labrador Retrievers and Border 258 
Collies, over 50% of dogs had displayed signs of separation anxiety by 18 months of age 259 
(Bradshaw, 2002).In future studies, owner involvement and other anxiety-reducing methods 260 
(e.g. extended habituation to the experimenter and the testing arena) may improve anxious 261 
dogs’ ability to perform the tasks. 262 
 263 
The testing used in this study was easily conducted in a non-specialised testing 264 
environment, and could be deployed in a clinical environment where sufficient floor space is 265 
available and distractions are minimised (e.g. the presence of other animals, food sources or 266 
strong scents). A key advantage of these tests of cognitive impairment over more extensive 267 
testing (e.g. delayed non-matching to position tasks) are that no prior is training of the dog is 268 
required, and could be conducted by veterinary staff acting as the tester, and the owner as the 269 
handler. Despite these advantages, modifications of these tasks may be required to improve 270 
their validity and reliability, Our Task 2 findings may suggest that problem solving ability is 271 
not affected by IE, however, dogs from both groups failed to access the food reward (IE: 6/15, 272 
Control: 4/14). During testing, it was also noted that the transparent plastic box holding the 273 
food reward could be easily flipped allowing access to the reward if the dog sniffed with enough 274 
force, rather than the container being manipulated with a paw. This may indicate that the task 275 
is not a valid means of assessing problem solving ability in dogs, and that amendments are 276 
needed to the procedure (e.g. heavier container that cannot be accidentally flipped, or a 277 
container weighted relatively to the size of the dog) and/or the scoring system (e.g. measure 278 
time to food reward acquisition or means of acquiring reward) to improve this tasks’ ability to 279 
measure cognitive abilities. From a post-hoc power analysis for task two, this element of the 280 
study was underpowered. In the control group, greater variation in performance was seen in 281 
task to compared to task one, and as such a large sample size would be required to detect a 282 
significant difference between these groups. This task requires further modifications to both 283 
the protocol and scoring system (as suggested above), along with an increased sample size to 284 
further understand this result. 285 
 286 
The CCDR scores differed between groups, with IE dogs scoring higher than controls, 287 
but no dog meeting the threshold for diagnosis of CCD (CCDR ≥50). In combination with the 288 
results of Task 1, this suggests that dogs with IE are cognitively impaired when compared to 289 
control dogs of a similar age and breed. The fact that no dog met the threshold for diagnosis 290 
suggests that the cognitive impairments seen are not as great as those observed in clinical cases 291 
of age-related cognitive dysfunction, or differ in their presentation.  292 
 293 
Further study is required to further our understanding of cognitive impairments and 294 
their underlying pathology in canine IE. Our group have recently conducted extensive 295 
epidemiological studies of cognitive impairment in dogs with epilepsy compared to controls 296 
(n= 4051 dogs, of which n=286 meet IVETF tier 1 criteria for epilepsy diagnosis). Using two 297 
metrics of canine cognition, a validated ‘trainability’ score (Packer, In Press) and the canine 298 
cognitive dysfunction rating scale (Packer, 2017), dogs with IE exhibited poorer trainability 299 
and a greater cognitive dysfunction score than controls. Within the epilepsy sup-population, 300 
dogs treated with polytherapy (2 or more AEDs), potassium bromide and/or zonisamide 301 
exhibited significantly lower trainability scores (Packer, In Press), and dogs with a history of 302 
cluster seizures and a higher seizure frequency exhibited significantly higher CCDR scores 303 
(Packer, 2017). The preliminary results of the present study combined with these findings add 304 
strength to the argument that, as in people with epilepsy, dogs with naturally occurring IE are 305 
also affected by impaired cognition. 306 
 307 
In conclusion, this preliminary study suggests that dogs with IE have a significantly 308 
reduced performance in a working spatial memory task compared with breed matched controls, 309 
but not in a problem solving task. Although cognitive impairment may not present a direct 310 
negative effect upon canine welfare, the trainability of a companion dog is considered 311 
important in maintaining a positive dog-owner relationship, and avoiding relationship 312 
breakdowns that may result in relinquishment {Salman, 2000 #225}. As such, identifying areas 313 
of cognitive compromise associated with chronic disease is of importance in companion 314 
animal. Further study utilising a larger study population and tasks exploring other areas of 315 
cognition are required to confirm the presence and nature of cognitive deficits associated with 316 
epilepsy and its treatment in the dog. 317 
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  404 
Figure legends 405 
 406 
Figure 1:  Diagram of the study room and locations of dog, owner and rewards during 407 
the tasks. Room dimensions: 6.5m x 5.5m. 1,2,3 denote food reward placement for task 1 on 408 
the 1st, 2nd and 3rd repeats respectively. 409 
 410 
 411 
  412 
Figure 2: Box and whisker diagrams of the median overall scores for each dog in each 413 
group for task 1 (P=0.016) and task 2  (P=0.683).  414 
 415 
 416 
  417 
Figure 3: A box and whisker diagram showing the distribution of CCDR scores 418 
(P=0.016) within the IE group and the control group. 419 
 420 
 421 
  422 
Table legends 423 
Table 1: Differences in task performance and cognitive dysfunction rating scale between 424 
the group with idiopathic epilepsy and control dogs 425 
 426 
 Idiopathic epilepsy group Control group (n=14)  
 
P value 
Median score [25th 
& 75th percentiles] 
Number 
of dogs 
Median score [25th & 
75th percentiles] 
Task 1 2 [1-2] 14 1 [1-1] P= 0.009 
Task 2 1 [1-2] 15 1 [1-2] P= 0.683 
CCDR 35 [34-38] 15 34 [34-34] P= 0.016 
 427 
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